1. He, Helen, Suryawanshi, Hemant, Morozov, Pavel, Tuschl, Thomas, Guttman-Yassky, Emma. 2020. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. In The Journal of allergy and clinical immunology, 145, 1615-1628. doi:10.1016/j.jaci.2020.01.042. https://pubmed.ncbi.nlm.nih.gov/32035984/
2. Potaczek, Daniel P, Przytulska-Szczerbik, Aleksandra, Bazan-Socha, Stanisława, Undas, Anetta, Wypasek, Ewa. 2020. Interaction between functional polymorphisms in FCER1A and TLR2 and the severity of atopic dermatitis. In Human immunology, 81, 709-713. doi:10.1016/j.humimm.2020.08.002. https://pubmed.ncbi.nlm.nih.gov/32883546/
3. Savas, Hulya, Ozkol, Hatice Uce, Gorgisen, Gokhan, Metin, Ahmet, Özdemir, İlknur Yorgun. 2024. The relationship between Fc epsilon receptor-1α and β (FCER1A and FCER1B) gene polymorphisms in patients with chronic urticaria using omalizumab. In Postepy dermatologii i alergologii, 41, 357-363. doi:10.5114/ada.2024.142285. https://pubmed.ncbi.nlm.nih.gov/39290894/
4. Mishra, Neha, Aden, Konrad, Blase, Johanna I, Schreiber, Stefan, Rosenstiel, Philip. 2022. Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease. In Genome medicine, 14, 110. doi:10.1186/s13073-022-01112-z. https://pubmed.ncbi.nlm.nih.gov/36153599/
5. Potaczek, Daniel P, Michel, Sven, Sharma, Vishwas, Illig, Thomas, Kabesch, Michael. 2013. Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics. In Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 24, 441-9. doi:10.1111/pai.12083. https://pubmed.ncbi.nlm.nih.gov/23725541/
6. Potaczek, D P, Sanak, M, Nishiyama, C, Ogawa, H, Szczeklik, A. . FCER1A gene proximal promoter polymorphisms in Caucasians and East Asians. In International journal of immunogenetics, 35, 339-40. doi:10.1111/j.1744-313X.2008.00784.x. https://pubmed.ncbi.nlm.nih.gov/18680511/